Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TLK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MAT2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL2L13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL1RN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930400 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF19B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKIRIN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM13A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD59 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLXNA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMGCL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRYL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKR1C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on